Report      Database

    Cervical Cancer Test Market & Patients (Pap Smear HPV DNA VIA) Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)

    Date: 04 Jan, 2017              Type: Diagnostics              Pages: 121

    Cervical Cancer Test Market & Patients (Pap Smear HPV DNA VIA) Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)
    • Electronic Access - Single User License
      $1,250.00
    • CD-ROM Mail Delivery
      $1,350.00
    • Hard-copy Mail Delivery
      $1,400.00
    • Electronic Access - Multi User License
      $2,050.00

    Get Free 10% Customization in This Report

    Cervical Cancer Test Market & Patients (Pap Smear, HPV DNA, VIA) in Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia) report published by Renub Research provides a comprehensive analysis of this market and future evolution over the next 5 years. This 121 page report with 118 Figures and 4 Table provides a complete analysis of top 8 Countries Cervical Cancer Test Market & Population

    Cervical cancer test market in Asian region is growing and expected to cross over Billion dollars by 2020. Despite declining women population, Japan has highest market share in cervical cancer test market. Whereas Indonesia is dominating in cervical cancer testing population followed by China. Growing women population, rising sum of structured cervical cancer programs introduced by governments and international NGOs and inception of low cost VIA test are some of the major growth drivers for the growth of cervical cancer test market in the developing countries.  

    All the 8 Asian countries in the report have been studied from 3 viewpoints. 

    Asia Cervical Cancer Test Market, Volume & Mortality

    1.    Cervical cancer Test Population (2008 – 2020)
    •    Pap smear test population (2008 – 2020) 
    •    HPV DNA test population (2008 – 2020)
    •    VIA test Population (2008 – 2020) 

    2.    Cervical Cancer Mortality Population (2001 – 2011) 

    3.    Cervical Cancer Test Market (2008 – 2020) 
    •    Pap smear test market (2008 – 2020)
    •    HPV DNA test market (2008 – 2020)
    •    VIA test market (2008 – 2020)

     

    All the 8 Countries studied in the report are as follows

    1.    Japan
    2.    Korea
    3.    Singapore
    4.    Malaysia
    5.    India
    6.    China
    7.    Thailand
    8.    Indonesia

     

    Data Sources

    This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

    Primary sources include industry surveys and telephone interviews with industry experts.

    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

    1.    Executive Summary

    2.    Asia Cervical Cancer Test (Screening) Population & Forecast

    3.    Asia Cervical Cancer Test (Screening) Market & Forecast
    3.1    Asia Cervical Cancer Pap Smear Test (Screening) Market & Forecast
    3.2    Asia Cervical Cancer HPV DNA Test (Screening) Market & Forecast
    3.3    Asia - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market & Forecast

    4.    Asia Cervical Cancer Test (Screening) Population Share & Forecast
    4.1    Asia Cervical Cancer Test (Screening) Population Share & Forecast

    5.    Asia Cervical Cancer Test (Screening) Market Share & Forecast
    5.1    Asia Cervical Cancer Test (Screening) Market Share & Forecast
    5.2    Asia Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
    5.3    Asia Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast
    5.4    Asia Cervical Cancer VIA Test (Screening) Market Share & Forecast

    6.    Japan – Cervical Cancer Test Analysis
    6.1    Japan Cervical Cancer Test (Screening) Population
    6.1.1    Japan Cervical Cancer Pap Smear Test Population & Forecast
    6.1.2    Japan Cervical Cancer HPV DNA Test Population & Forecast

    6.2    Japan Cervical Cancer Mortality

    6.3    Japan Cervical Cancer Test (Screening) Market
    6.3.1    Japan Cervical Cancer Test Market & Forecast
    6.3.2    Japan Pap Smear Test Market & Forecast
    6.3.3    Japan HPV DNA Test Market & Forecast

    7.    South Korea – Cervical Cancer Tests Analysis
    7.1    South Korea - Cervical Cancer Test (Screening) Population
    7.1.1    South Korea - Cervical Cancer Pap Smear Test Population & Forecast
    7.1.2    Korea Cervical Cancer HPV DNA Test Population & Forecast

    7.2    Korea Cervical Cancer Mortality

    7.3    Korea Cervical Cancer Test (Screening) Market
    7.3.1    Korea Cervical Cancer Test Market & Forecast
    7.3.2    Korea Pap Smear Test Market & Forecast
    7.3.3    Korea HPV DNA Test Market & Forecast

    8.    Singapore – Cervical Cancer Tests Analysis
    8.1    Singapore - Cervical Cancer Test (Screening) Population
    8.1.1    Singapore - Cervical Cancer Pap Smear Test Population & Forecast
    8.1.2    Singapore Cervical Cancer HPV DNA Test Population & Forecast

    8.2    Singapore Cervical Cancer Test (Screening) Market
    8.2.1    Singapore Cervical Cancer Test Market & Forecast
    8.2.2    Singapore Pap Smear Test Market & Forecast
    8.2.3    Singapore HPV DNA Test Market & Forecast

    9.    Malaysia – Cervical Cancer Test Analysis
    9.1    Malaysia - Cervical Cancer Test (Screening) Population
    9.1.1    Malaysia Cervical Cancer Pap Smear Test Population & Forecast
    9.1.2    Malaysia Cervical Cancer HPV DNA Test Population & Forecast

    9.2    Malaysia Cervical Cancer Test (Screening) Market
    9.2.1    Malaysia Cervical Cancer Test Market & Forecast
    9.2.2    Malaysia Pap Smear Test Market & Forecast
    9.2.3    Malaysia HPV DNA Test Market & Forecast

    10.    India – Cervical Cancer Test Analysis
    10.1    India - Cervical Cancer Test (Screening) Population
    10.1.1    India Cervical Cancer Pap Smear Test Population & Forecast
    10.1.2    India Cervical Cancer HPV DNA Test Population & Forecast
    10.1.3    India Cervical Cancer VIA Test Population & Forecast

    10.2    India Cervical Cancer Test (Screening) Market
    10.2.1    India Cervical Cancer Test Market & Forecast
    10.2.2    India Pap Smear Test Market & Forecast
    10.2.3    India HPV DNA Test Market & Forecast
    10.2.4    India VIA Test Market & Forecast

    11.    China – Cervical Cancer Test Analysis
    11.1    China - Cervical Cancer Test (Screening) Population
    11.1.1    China Cervical Cancer Pap smear Test Population & Forecast
    11.1.2    China Cervical Cancer HPV DNA Test Population & Forecast
    11.1.3    China Cervical Cancer VIA Test Population & Forecast

    11.2    China - Cervical Cancer Test (Screening) Market
    11.2.1    China Cervical Cancer Test Market & Forecast
    11.2.2    China Pap Smear Test Market & Forecast
    11.2.3    China HPV DNA Test Market & Forecast
    11.2.4    China VIA Test Market & Forecast

    12.    Thailand – Cervical Cancer Test Analysis
    12.1    Thailand - Cervical Cancer Test (Screening) Population
    12.1.1    Thailand Cervical Cancer Pap Smear Test Population & Forecast
    12.1.2    Thailand Cervical Cancer VIA Test Population & Forecast

    12.2    Thailand Cervical Cancer Test (Screening) Market
    12.2.1    Thailand Cervical Cancer Test Market & Forecast
    12.2.2    Thailand Pap smear Test Market & Forecast
    12.2.3    Thailand VIA Test Market & Forecast

    13.    Indonesia – Cervical Cancer Test Analysis
    13.1    Indonesia Cervical Cancer Test (Screening) Population
    13.1.1    Indonesia Cervical Cancer Pap Smear Test Population & Forecast
    13.1.2    Indonesia Cervical Cancer HPV DNA Test Population & Forecast
    13.1.3    Indonesia Cervical Cancer VIA Test Population & Forecast
    13.1.4    Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast

    13.2    Indonesia Cervical Cancer Test (Screening) Market
    13.2.1    Indonesia Cervical Cancer Test Market & Forecast
    13.2.2    Indonesia Pap smear Test Market & Forecast
    13.2.3    Indonesia HPV DNA Test Market & Forecast
    13.2.4    Indonesia VIA Test Market & Forecast
    13.2.5    Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast

    14.    Cervical Cancer Test Market Growth Drivers
    14.1    Introduction of Low Cost VIA Test
    14.1.1    Countries Offering VIA Test via National Programs
    14.1.2    Countries Offering VIA Test via Pilot Programs

    14.2    Worldwide Rising Incidence of Teenage Sexual Cases

    14.3    High Prevalence of HPV Infected Patients Globally

    15.    Challenges in Cervical Cancer Test Market
    15.1    Lack of Appropriate Healthcare Infrastructure
    15.2    Introduction of HPV Vaccination Programs Worldwide

    List of Figures:

    Figure 2 1: Asia – Cervical Cancer Test Population (Million), 2008 – 2015
    Figure 2 2: Asia – Forecast for Cervical Cancer Test Population (Million), 2016 – 2020

    Figure 3 1: Asia – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 3 2: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 3 3: Asia – Cervical Cancer Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 3 4: Asia – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 3 5: Asia – Cervical Cancer HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 3 6: Asia – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 3 7: Asia – Cervical Cancer VIA Test Market (Million US$), 2008 – 2015
    Figure 3 8: Asia – Forecast for Cervical Cancer VIA Test Market (Million US$), 2016 – 2020

    Figure 4 1: Asia – Cervical Cancer Test Population Share (Percent), 2008 – 2015
    Figure 4 2: Asia – Forecast for Cervical Cancer Test Population Share (Percent), 2016 – 2020

    Figure 5 1: Asia – Cervical Cancer Test Market Share (Percent), 2008 – 2015
    Figure 5 2: Asia – Forecast for Cervical Cancer Test Market Share (Percent), 2016 – 2020
    Figure 5 3: Asia – Cervical Cancer Pap Smear Test Market Share (Percent), 2008 – 2015
    Figure 5 4: Asia – Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016 – 2020
    Figure 5 5: Asia – Cervical Cancer HPV DNA Test Market Share (Percent), 2008 – 2015
    Figure 5 6: Asia – Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016 – 2020
    Figure 5 7: Asia – Cervical Cancer VIA Test Market Share (Percent), 2008 – 2015
    Figure 5 8: Asia – Forecast for Cervical Cancer VIA Test Market Share (Percent), 2016 – 2020

    Figure 6 1: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 6 2: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 6 3: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 6 4: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 6 5: Japan – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 6 6: Japan – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 6 7: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 6 8: Japan – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 6 9: Japan – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 6 10: Japan – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 6 11: Japan – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 7 1: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 7 2: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 7 3: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 7 4: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 7 5: Korea – Cervical Cancer Mortality (Number), 2001 – 2011
    Figure 7 6: Korea – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 7 7: Korea – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 7 8: Korea – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 7 9: Korea – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 7 10: Korea – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 7 11: Korea – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 8 1: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 8 2: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 8 3: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 8 4: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 8 5: Singapore – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 8 6: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 8 7: Singapore – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 8 8: Singapore – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 8 9: Singapore – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 8 10: Singapore – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 9 1: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 9 2: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 9 3: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 9 4: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 9 5: Malaysia – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 9 6: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 9 7: Malaysia – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 9 8: Malaysia – Forecast for Pap smear Test Market (Million US$), 2016 – 2020
    Figure 9 9: Malaysia – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 9 10: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020

    Figure 10 1: India – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 10 2: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 10 3: India – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 10 4: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 10 5: India – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 10 6: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 10 7: India – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 10 8: India – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 10 9: India – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 10 10: India – Forecast for Pap smear Test Market (Million US$), 2016 – 2020
    Figure 10 11: India – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 10 12: India – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 10 13: India – VIA Test Market (Million US$), 2008 – 2015
    Figure 10 14: India – Forecast for VIA Test Market (Million US$), 2016 – 2020

    Figure 11 1: China – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 11 2: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 11 3: China – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 11 4: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 11 5: China – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 11 6: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 11 7: China – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 11 8: China – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 11 9: China – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 11 10: China – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 11 11: China – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 11 12: China – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 11 13: China – VIA Test Market (Million US$), 2008 – 2015
    Figure 11 14: China – Forecast for VIA Test Market (Million US$), 2016 – 2020

    Figure 12 1: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 12 2: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 12 3: Thailand – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 12 4: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 12 5: Thailand – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 12 6: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 12 7: Thailand – Pap smear Test Market (Million US$), 2008 – 2015
    Figure 12 8: Thailand – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 12 9: Thailand – VIA Test Market (Million US$), 2008 – 2015
    Figure 12 10: Thailand – Forecast for VIA Test Market (Million US$), 2016 – 2020

    Figure 13 1: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2008 – 2015
    Figure 13 2: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 – 2020
    Figure 13 3: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2008 – 2015
    Figure 13 4: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 – 2020
    Figure 13 5: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2008 – 2015
    Figure 13 6: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2016 – 2020
    Figure 13 7: Indonesia – Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2008 – 2015
    Figure 13 8: Indonesia – Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2016 – 2020
    Figure 13 9: Indonesia – Cervical Cancer Test Market (Million US$), 2008 – 2015
    Figure 13 10: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2016 – 2020
    Figure 13 11: Indonesia – Pap Smear Test Market (Million US$), 2008 – 2015
    Figure 13 12: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2016 – 2020
    Figure 13 13: Indonesia – HPV DNA Test Market (Million US$), 2008 – 2015
    Figure 13 14: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2016 – 2020
    Figure 13 15: Indonesia – VIA Test Market (Million US$), 2008 – 2015
    Figure 13 16: Indonesia – Forecast for VIA Test Market (Million US$), 2016 – 2020
    Figure 13 17: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2008 – 2015
    Figure 13 18: Indonesia – Forecast for Both (Pap Smear & VIA) Test Market (Million US$), 2016 – 2020



    List of Tables:

    Table 25 1: Worldwide – List of Countries which offer VIA Test via National Programs, 2015
    Table 25 2: Worldwide – List of Countries which offer VIA Test via Pilot Programs, 2015
    Table 25 3: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006
    Table 25 4: Worldwide – HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010


    Related Products